Jefferies Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-50,615
| Closed | -$1.91K | – | 855 |
|
2020
Q2 | $1.91K | Sell |
50,615
-815
| -2% | -$31 | 0.02% | 317 |
|
2020
Q1 | $1.47M | Buy |
51,430
+37,657
| +273% | +$1.07M | 0.02% | 377 |
|
2019
Q4 | $714K | Buy |
13,773
+2,330
| +20% | +$121K | 0.01% | 895 |
|
2019
Q3 | $628K | Buy |
11,443
+6,008
| +111% | +$330K | ﹤0.01% | 970 |
|
2019
Q2 | $221K | Sell |
5,435
-85,510
| -94% | -$3.48M | ﹤0.01% | 1268 |
|
2019
Q1 | $2.75M | Buy |
+90,945
| New | +$2.75M | 0.02% | 347 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 1395 |
|
2018
Q3 | – | Sell |
-6,856
| Closed | -$219K | – | 1601 |
|
2018
Q2 | $219K | Buy |
+6,856
| New | +$219K | ﹤0.01% | 1301 |
|
2017
Q3 | – | Sell |
-4,108
| Closed | -$203K | – | 1526 |
|
2017
Q2 | $203K | Sell |
4,108
-1,693
| -29% | -$83.7K | ﹤0.01% | 1332 |
|
2017
Q1 | $252K | Buy |
+5,801
| New | +$252K | ﹤0.01% | 1189 |
|
2014
Q3 | – | Sell |
-5,484
| Closed | -$254K | – | 1398 |
|
2014
Q2 | $254K | Buy |
+5,484
| New | +$254K | ﹤0.01% | 1031 |
|